Axsome Therapeutics (AXSM) Misses Q1 EPS by 3c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'
• Morgan Stanley Resumes American Eagle Outfitters (AEO) at Equalweight